98-24002. Dental Plaque Subcommittee of the Nonprescription Drugs Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 173 (Tuesday, September 8, 1998)]
    [Notices]
    [Page 47504]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-24002]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Dental Plaque Subcommittee of the Nonprescription Drugs Advisory 
    Committee; Notice of Meeting
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION:  Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Dental Plaque Subcommittee of the 
    Nonprescription Drugs Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on October 22 and 23, 1998, 
    8:30 a.m. to 5 p.m.
        Location: Town Center Hotel, The Maryland Ballroom, 8727 Colesville 
    Rd., Silver Spring, MD.
        Contact Person: Robert L. Sherman or Stephanie A. Mason, Center for 
    Drug Evaluation and Research (HFD-560), Food and Drug Administration, 
    5600 Fishers Lane, Rockville, MD, 301-827-5191, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12541. Please call the Information Line for 
    up-to-date information on this meeting.
        Agenda: The subcommittee will discuss: (1) The safety and efficacy 
    of the combination of triclosan and zinc citrate and vote on the 
    combination of zinc chloride, sodium citrate, hydrogen peroxide and 
    sodium lauryl sulfate; (2) professional labeling for over-the-counter 
    (OTC) antiplaque-antigingivitis drug products; and (3) the elements of 
    their recommendations concerning OTC antiplaque-antigingivitis drug 
    products, which will continue on October 23, 1998.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by October 15, 
    1998. Oral presentations from the public will be scheduled on October 
    22 between approximately 11 a.m. and 12 m. Time allotted for each 
    presentation may be limited. Those desiring to make formal oral 
    presentations should notify the contact person before October 15, 1998, 
    and submit a brief statement of the general nature of the evidence or 
    arguments they wish to present, the names and addresses of proposed 
    participants, and an indication of the approximate time requested to 
    make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: September 1, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-24002 Filed 9-4-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
09/08/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-24002
Pages:
47504-47504 (1 pages)
PDF File:
98-24002.pdf